» Articles » PMID: 27072868

Scottish Keep Well Health Check Programme: an Interrupted Time Series Analysis

Overview
Specialty Health Services
Date 2016 Apr 14
PMID 27072868
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Effective interventions are available to reduce cardiovascular risk. Recently, health check programmes have been implemented to target those at high risk of cardiovascular disease (CVD), but there is much debate whether these are likely to be effective at population level. This paper evaluates the impact of wave 1 of Keep Well, a Scottish health check programme, on cardiovascular outcomes.

Methods: Interrupted time series analyses were employed, comparing trends in outcomes in participating and non-participating practices before and after the introduction of health checks. Health outcomes are defined as CVD mortality, incident hospitalisations and prescribing of cardiovascular drugs.

Results: After accounting for secular trends and seasonal variation, coronary heart disease mortality and hospitalisations changed by 0.4% (95% CI -5.2% to 6.3%) and -1.1% (-3.4% to 1.3%) in Keep Well practices and by -0.3% (-2.7% to 2.2%) and -0.1% (-1.8% to 1.7%) in non-Keep Well practices, respectively, following the intervention. Adjusted changes in prescribing in Keep Well and non-Keep Well practices were 0.4% (-10.4% to 12.5%) and -1.5% (-9.4% to 7.2%) for statins; -2.5% (-12.3% to 8.4%) and -1.6% (-7.1% to 4.3%) for antihypertensive drugs; and -0.9% (-6.5% to 5.0%) and -2.4% (-10.1% to 6.0%) for antiplatelet drugs.

Conclusions: Any impact of the Keep Well health check intervention on CVD outcomes and prescribing in Scotland was very small. Findings do not support the use of the screening approach used by current health check programmes to address CVD. We used an interrupted time series method, but evaluation methods based on randomisation are feasible and preferable and would have allowed more reliable conclusions. These should be considered more often by policymakers at an early stage in programme design when there is uncertainty regarding programme effectiveness.

Citing Articles

Effectiveness of the Mobile Emergency Medical Services (SAMU): use of interrupted time series.

Oliveira C, Novaes H, Alencar A, Santos I, Damasceno M, de Souza H Rev Saude Publica. 2019; 53:99.

PMID: 31800916 PMC: 6863106. DOI: 10.11606/s1518-8787.2019053001396.


Do cardiovascular disease prevention programs in northern Sweden impact on population health? An interrupted time series analysis.

San Sebastian M, Mosquera P, Gustafsson P BMC Public Health. 2019; 19(1):202.

PMID: 30770750 PMC: 6377762. DOI: 10.1186/s12889-019-6514-x.


Allostatic load as a predictor of all-cause and cause-specific mortality in the general population: Evidence from the Scottish Health Survey.

Robertson T, Beveridge G, Bromley C PLoS One. 2017; 12(8):e0183297.

PMID: 28813505 PMC: 5559080. DOI: 10.1371/journal.pone.0183297.


NHS Health Check comorbidity and management: an observational matched study in primary care.

Robson J, Dostal I, Madurasinghe V, Sheikh A, Hull S, Boomla K Br J Gen Pract. 2016; 67(655):e86-e93.

PMID: 27993901 PMC: 5308122. DOI: 10.3399/bjgp16X688837.

References
1.
Robson J, Dostal I, Sheikh A, Eldridge S, Madurasinghe V, Griffiths C . The NHS Health Check in England: an evaluation of the first 4 years. BMJ Open. 2016; 6(1):e008840. PMC: 4735215. DOI: 10.1136/bmjopen-2015-008840. View

2.
Forster A, Burgess C, Dodhia H, Fuller F, Miller J, McDermott L . Do health checks improve risk factor detection in primary care? Matched cohort study using electronic health records. J Public Health (Oxf). 2015; 38(3):552-559. PMC: 5072161. DOI: 10.1093/pubmed/fdv119. View

3.
McCartney G, Fischbacher C, Muirie J, Brown L . Effectiveness of a national cardiovascular disease risk assessment programme: a different view. Prev Med. 2013; 59:83. DOI: 10.1016/j.ypmed.2013.10.024. View

4.
Taylor F, Huffman M, Macedo A, Moore T, Burke M, Davey Smith G . Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013; (1):CD004816. PMC: 6481400. DOI: 10.1002/14651858.CD004816.pub5. View

5.
Baigent C, Keech A, Kearney P, Blackwell L, Buck G, Pollicino C . Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005; 366(9493):1267-78. DOI: 10.1016/S0140-6736(05)67394-1. View